FindTrial
Sign In

weak magnetic fields against pain in fibromyalgia

weak magnetic fields against pain in fibromyalgia - pemFMS

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41810
Enrollment
30
Registered
2015-10-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medisch onbegrepen klachten weak parts reuma

Interventions

Intervention (if applicable): One group receives 30 minutes of PEMF treatment per day for five days per week, for five weeks in a row (PEMF group). The other group receives placebo (SHAM group) for

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: fibromyalgia pain

Exclusion criteria

Exclusion criteria: severe psychiatric illness neurological disorder change in medication/ongoing therapy during study and 4 weeks before

Design outcomes

Primary

MeasureTime frame
Cerebral functioning (fMRI) t rest and during a movement task—

Secondary

MeasureTime frame
Visual Analoge Scale for pain (0-10), change in score between baseline (week 0) and endpoint (week 5) and Fibromyalgie Score (FS) (sum WPI and SS, see protocol, and psychological well-being (questionnaires)—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)